Johnson & Johnson: buy signal launched, strength still building

Johnson & Johnson issues a fresh buy signal at week 1 on BATS. Signal strength stands at 38 out of 100 — medium, leaning weak — and the stock ranks 12th among 13 fresh US Long signals. The Health Care sector is in a positive regime. The case is tradeable, but the model calls for reduced sizing and the confirmation week is still in progress.